Laurent G, Hildebrand J, Thys O
Lab Invest. 1975 May;32(5):580-4.
To elucidate the mode of action of AC-3579, a diazafluoranthen derivative, the effects of the drug were tested, in incubations with rat liver homogenates on three phospholipases: the endogenous microsomal phospholipase A and the exogenous phospholipases A2 and C. The rates of hydrolysis of phosphatidylcholine and phosphatidylethanolamine, the main liver phospholipids, were significantly decreased in liver of treated animals. This inhibition was more marked in experiments with exogenous phospholipase A than with phospholipase C. For phospholipid the difference observed may be due to the decrease in activity of endogenous phospholipase A in livers of treated rats. On the other hand, the addition to the incubation media of AC-3579 or of homogenates of AC-3579-treated rat livers did not modify the action of the three phospholipases on phospholipids from normal rat liver homogenates. It is concluded that AC-3579 forms with the hydrophobic moiety of the phospholipids of smooth endoplasmic reticulum a reversible complex less accessible to the activity of phospholipase A. This mechanism accounts for the decrease in phospholipid catabolism, previously observed in vivo, which leads to hypertrophy of smooth endoplasmic reticulum and to the formation of lamellate cytosomes.
为阐明二氮杂芴衍生物AC - 3579的作用模式,在与大鼠肝脏匀浆共同孵育的条件下,对该药物作用于三种磷脂酶的效果进行了测试,这三种磷脂酶分别是内源性微粒体磷脂酶A以及外源性磷脂酶A2和C。在接受治疗动物的肝脏中,主要的肝脏磷脂——磷脂酰胆碱和磷脂酰乙醇胺的水解速率显著降低。在外源性磷脂酶A实验中,这种抑制作用比在磷脂酶C实验中更为明显。对于磷脂而言,观察到的差异可能是由于接受治疗大鼠肝脏中内源性磷脂酶A活性降低所致。另一方面,向孵育介质中添加AC - 3579或经AC - 3579处理的大鼠肝脏匀浆,并不会改变这三种磷脂酶对正常大鼠肝脏匀浆中磷脂的作用。得出的结论是,AC - 3579与滑面内质网磷脂的疏水部分形成一种可逆复合物,使得磷脂酶A的活性较难作用于该复合物。这一机制解释了先前在体内观察到的磷脂分解代谢减少的现象,这种减少会导致滑面内质网肥大以及层状胞质小体的形成。